North America Analysis
Home Jim Gilligan Ph.D. MSIB – Tryp Therapeutics, Inc

    Jim Gilligan

    CEO & CSO
    Tryp Therapeutics, Inc

    Jim is a scientist, entrepreneur, executive, and business development specialist

    With >35 years of drug development experience, Jim encompasses all facets of the drug development continuum.

    As an author and co-author of healthcare-related patents, he understands the importance, complexity and necessity of establishing a strong IP portfolio, especially in the natural products arena.

    Contributor's Details

    Phone: +1 973 385 9295
    Website: Visit Website